Comparison

Nicotinamide N-oxide European Partner

Item no. TMO-T0617-200mg
Manufacturer TargetMol
CASRN 1986-81-8
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 1 mL 200 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,999
Citations 1. Tian YJ, et al. Br J Nutr. 2014 May;111(9):1594-601.
Smiles NC(=O)C1=CC=C[N+]([O-])=C1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Nicotinamide-N-oxide,Nicotinamide 1-oxide,1-oxynicotinamide
Shipping Condition Cool pack
Available
Manufacturer - Targets
Drug Metabolite|||CXCR|||Endogenous Metabolite|||c-Myc
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
138.12
Description
Nicotinamide N-oxide (Nicotinamide 1-oxide) is recognized as an in vivo metabolite of nicotinamide which is a precurser of nicotinamide-adenine dinucleotide (NAD+) in animals. The enzyme that catalyzes the reduction of nicotinamide N-oxide to nicotinamide in the liver is xanthine oxidase.
Pathways
Autophagy|||GPCR/G Protein|||Metabolism|||Cell Cycle/Checkpoint|||Immunology/Inflammation
Bioactivity
Nicotinamide N-oxide is recognized as an in vivo metabolite of nicotinamide which is a precurser of nicotinamide-adenine dinucleotide (NAD+) in animals. The enzyme that catalyzes the reduction of nicotinamide N-oxide to nicotinamide in the liver is xanthine oxidase.
Receptor
c-Myc

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close